Charles B. Nemeroff
|
This article is part of the Pharma_Portal project of Spinwatch. |
Charles B. Nemeroff, M.D., Ph.D., is professor and chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.[1] Previously, he spent 18 years at the Emory University School of Medicine in Atlanta. He is the former Editor-in-Chief of Neuropsychopharmacology, the journal of the American College of Neuropsychopharmacology(ACNP). [2]
Controversies
GlaxoSmithKline Payment Disclosures
In 2008, Nemeroff was accused of failing to disclose $500,000 worth of payments from GSK. [3] At the time, he was the main investigator of a collaborative project between Emory University, GSK and the US government’s National Institute of Mental Health investigating ‘five novel GSK antidepressants’. [4]
Notes
- ↑ University of MiamiUM Miller School of Medicine Names New Chair of Psychiatry] Accessed 30 January 2010.
- ↑ Emory University.Psychiatry: Emory Accessed 2 February 2010.
- ↑ Goldstein, J.The Wall Street Journal. 3 October 2008. Grassley says Emory Psychiatrist Didnt Report 500,000 in Payments Accessed 3 February 2010.
- ↑ Grassley, C. 2 October 2008. Senate Letter Accessed 2 February 2010.
